T-tubule remodeling in human hypertrophic cardiomyopathy.
Giulia VitaleRaffaele CoppiniChiara TesiCorrado PoggesiLeonardo SacconiCorrado PoggesiPublished in: Journal of muscle research and cell motility (2020)
The highly organized transverse T-tubule membrane system represents the ultrastructural substrate for excitation-contraction coupling in ventricular myocytes. While the architecture and function of T-tubules have been well described in animal models, there is limited morpho-functional data on T-tubules in human myocardium. Hypertrophic cardiomyopathy (HCM) is a primary disease of the heart muscle, characterized by different clinical presentations at the various stages of its progression. Most HCM patients, indeed, show a compensated hypertrophic disease ("non-failing hypertrophic phase"), with preserved left ventricular function, and only a small subset of individuals evolves into heart failure ("end stage HCM"). In terms of T-tubule remodeling, the "end-stage" disease does not differ from other forms of heart failure. In this review we aim to recapitulate the main structural features of T-tubules during the "non-failing hypertrophic stage" of human HCM by revisiting data obtained from human myectomy samples. Moreover, by comparing pathological changes observed in myectomy samples with those introduced by acute (experimentally induced) detubulation, we discuss the role of T-tubular disruption as a part of the complex excitation-contraction coupling remodeling process that occurs during disease progression. Lastly, we highlight how T-tubule morpho-functional changes may be related to patient genotype and we discuss the possibility of a primitive remodeling of the T-tubule system in rare HCM forms associated with genes coding for proteins implicated in T-tubule structural integrity, formation and maintenance.
Keyphrases
- hypertrophic cardiomyopathy
- left ventricular
- heart failure
- endothelial cells
- cardiac resynchronization therapy
- mitral valve
- aortic stenosis
- acute myocardial infarction
- left atrial
- induced pluripotent stem cells
- end stage renal disease
- electronic health record
- atrial fibrillation
- ejection fraction
- drug induced
- newly diagnosed
- big data
- prognostic factors
- skeletal muscle
- oxidative stress
- room temperature
- quantum dots
- genome wide
- chronic kidney disease
- smooth muscle
- bioinformatics analysis
- aortic dissection
- patient reported outcomes
- deep learning
- energy transfer